Joinhub Pharma Llp - Due diligence report
A 360° intelligence report on Joinhub Pharma Llp: trust score, financial health, credit view, compliance, directors, growth and distress sig…
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Joinhub Pharma Llp — 360° Intelligence Report
Generated from MCA filings & public recordsJoinhub Pharma Llp is assessed as Low Risk with a Trust Score of 87/100. Joinhub Pharma Llp is an active limited liability partnership incorporated in 2020, operating in the Pharma sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.
Report generated on 21 Aug 2026 from the latest processed filings. Joinhub Pharma Llp snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
Score Card
Higher is safer · rule-based & explainableFinancial Intelligence Dashboard
Standalone · 4 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
Credit & Compliance Intelligence
Why the scores are what they are- Profitable - internal accruals available.
Charges position: 3 open (60.63 cr) · 0 satisfied (-).
| Lender | Charges | Amount |
|---|---|---|
| Saraswat Co Operative Bank Ltd | 2 | 48.0 cr |
| Saraswat Co Operative Bank Ltd Naranpura Branch | 1 | 48.0 cr |
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- 1 active GST registration(s).
Director Intelligence
Stability score: 85/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| ABBASALI MAHAMMADALI BALOSPURA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Ahemadabbas Gulamhaidar Balospura | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| AABID ALI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 3 directors on the board.
- No disqualified or deactivated DINs.
- 1 director exit(s) in the last 3 years.
Ownership & Group Intelligence
Full shareholding pattern, group structure & capital events →
Risk Intelligence Center
Growth 80 · Distress 90Stakeholder Verdicts
Vendor · Banker · Investor- Statutory record is clean.
- No distress signals on file.
- Financial filings available for verification.
- Debt capacity assessed from filed statements.
- 3 open charge(s) of 60.63 cr already registered.
- Compliance record supports lending.
- 4 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
MCA Filings & Events Timeline
Latest 10 eventsKey Observations
Auto-generated from the data above| Company | CIN | Location |
|---|---|---|
| Prospect Pharmaceuticals Private Limited | U51909WB2017PTC221360 | Bishnupur - I, West Bengal, India |
| Shakun Medicals Private Limited | U24290UP2020PTC132881 | Lucknow, Uttar Pradesh, India |
| Remedex Pharma Private Limited | U74999KL2016PTC047213 | Thiruvananthapuram, Kerala, India |
| Esvee Pharma Chem Private Limited | U24231PN1999PTC013754 | Pune, Maharashtra, India |
| Dolvis Bio Pharma Private Limited | U24232CH2012PTC033674 | Manimajra, Chandigarh, India |
| Nicolo Exports India Pvt.Ltd. | U51109WB1994PTC064083 | Kolkata, West Bengal, India |
| Easylife Fresh Trading Private Limited | U52599MP2013PTC030060 | Indore, Madhya Pradesh, India |
| Avansdose Pharmatech Private Limited | U74999TG2017PTC115497 | Hyderabad, Telangana, India |
Who Uses This Report
CA · CS · Banker · Investor · VendorVerify Joinhub Pharma Llp before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Track statutory health of Joinhub Pharma Llp: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Current banker verdict: Favourable lending indicators. Credit risk score 65/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investor view: Positive growth indicators. Growth score 80/100, margin trends, ownership structure and peer set for Joinhub Pharma Llp - screening before a deeper diligence.
Vendor verdict: Favourable indicators. Trust score 87/100, distress signals and MSME payment-delay disclosures - know whether Joinhub Pharma Llp pays its suppliers before you extend credit terms.
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Joinhub Pharma Llp - groundwork for KYC, onboarding and disputes.
Frequently Asked Questions
Is Joinhub Pharma Llp an active company?
Joinhub Pharma Llp has MCA status “Active” with a compliance score of 100/100 (Low Risk).
Is Joinhub Pharma Llp financially healthy?
Joinhub Pharma Llp has a Financial Health Score of 75/100 (Low Risk) based on its filed financial statements.
Should I do business with Joinhub Pharma Llp?
Its overall Trust Score is 87/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Joinhub Pharma Llp?
See the directors and ownership sections above for board and shareholding detail. 3 active director(s) are on record.
Does Joinhub Pharma Llp have loans or charges against its assets?
3 open charge(s) are registered against its assets.
Is Joinhub Pharma Llp up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).
Is it risky to lend to Joinhub Pharma Llp?
Its Credit Risk Score is 65/100 (Moderate). Banker verdict: Favourable lending indicators.